Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02361346
Title Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (MT-3724NHL001)
Acronym MT-3724NHL001
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Molecular Templates, Inc.
Age Groups: adult | senior
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
University of Arizona Tucson Arizona 85724 United States Details
Innovative Clinical Research Institute, LLC Whittier California 90602 United States Details
21st Century Oncology - Jacksonville Jacksonville Florida 32204 United States Details
Orlando Health, Inc. Orlando Florida 32806 United States Details
Orlando Health, Inc. Orlando Florida United States Details
BRCR Medical Center Plantation Florida 33322 United States Details
ASCLEPES Research Centers Weeki Wachee Florida 34607 United States Details
Columbus Regional Research Institute Columbus Georgia 31904 United States Details
University of Illinois, Cancer Center Chicago Illinois 60612 United States Details
Healthcare Research Network III, LLC Tinley Park Illinois United States Details
Carle Foundation Hospital Urbana Illinois United States Details
Norton Healthcare, Inc Louisville Kentucky United States Details
New York University Langone Medical Center New York New York 10016 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
UT Health San Antonio Cancer San Antonio Texas 78229 United States Details
Grodno University Hospital Grodno Belarus Details
Minsk City Clinical Oncology Center Minsk 220013 Belarus Details
Cross Cancer Institute Edmonton Alberta Canada Details
Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston Ontario K7L 2V7 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Montreal Oncology Research Quebec H1M 1B1 Canada Details
LLC ARENSIA Exploratory Medicine Tbilisi 0112 Georgia Details
Rabin Medical Center, Davidoff Cancer Center, Hemato-Oncology Institute Petah-Tikva 49100 Israel Details
Chaim Sheba Medical Center, Department of Hematology Ramat Gan Israel Details
The Tel Aviv Sourasky Medical Center, Department of Hematology and Bone Marrow Transplantation Tel-Aviv Israel Details
ARENSIA Exploratory Medicine, Chisinau MD-2025 Moldova, Republic of Details
Maria Sklodowska-Curie National Institute of Oncology - National Research Institute Gliwice Poland Details
University Hospital in Krakow, Teaching Unit of the Hematology Department Kraków Poland Details
Frederic Chopin Provincial Teaching Hospital, Teaching Department of Hematology Rzeszów 35-055 Poland Details
Our Doctor Clinical Trials Center Torun Poland Details
Institute of Hematology and Transfusion Medicine, Department of Hematology Warsaw Poland Details
Jan Mikulicz Radecki University Hospital in Wroclaw, Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation Wroclaw 50-367 Poland Details
Clinical Center Kragujevac, Clinic of Hematology Kragujevac Serbia Details
Clinical Center of Vojvodina, Clinic of Hematology Novi Sad Serbia Details
Catalan Institute of Oncology (ICO) - Hospital Duran i Reynals, Department of Clinical Hematology Barcelona Spain Details
University Hospital Vall d'Hebron (HUVH), Department of Hematology Barcelona Spain Details
Hospital Universitario QuironSalud Madrid Madrid 28223 Spain Details
University Hospital Virgen del Rocio (HUVR), Department of Hematology Seville Spain Details
Medical Center of Limited Liability Company "Medical Centre Named by Academician Yurii Spizhenko Kyiv 08112 Ukraine Details
*Shaded cells indicate that there was no data available from for the field